Ponsegromab treatment led to sustained weight gain and GDF-15 suppression over 64 weeks in cancer-associated cachexia patients. Patients initially on placebo gained weight after switching to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback